News Positive Results from Phase 3 Study of CTx-1301 for ADHD Treatment Cingulate, a leading pharmaceutical company, has announced positive results from a Phase 3 study evaluating the efficacy and safety of its lead candidate, ... By Artur FernandoSeptember 11, 20230
BlackRock is reviewing TechBerry and negotiating a possible full or partial acquisition of the company June 20, 2024